(Q41094556)

26 September 2017

Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor (English)

1 reference

26 September 2017

N I Obiri

1

1 reference

26 September 2017

T Murata

series ordinal

2

1 reference

26 September 2017

W Debinski

series ordinal

3

1 reference

26 September 2017

R K Puri

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Journal of Biological Chemistry

26 September 2017

1 reference

26 September 2017

272

1 reference

26 September 2017

20251-20258

1 reference

26 September 2017

32

1 reference

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

26 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Interleukin-4 and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

cDNA cloning and characterization of the human interleukin 13 receptor alpha chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Cloning of the gamma chain of the human IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Up-regulation of intercellular adhesion molecule 1 (ICAM-1) on human renal cell carcinoma cells by interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.32.20251

21 January 2018

Identifiers

DOI

10.1074/JBC.272.32.20251

1 reference

26 September 2017

1 reference